RightFit
RecruitingEarly Phase 1

Noise-augmented Automatic Speech Recognition for Speech Treatment in Parkinson's Disease

Understand Me for Life: Using Noise-augmented Automatic Speech Recognition to Improve Intelligibility in Parkinson's Disease

Who can join

As published by the study on ClinicalTrials.gov. "Not stated" means the study hasn't said — ask the study team.

Age
50 Years to 80 Years
Sex
All sexes
Healthy volunteers
Not accepted
Compensation
Not stated

Other requirements are listed under Eligibility below. Only the study team can confirm whether you can join.

What to expect

No one can promise a trial will help you personally — that is what the research is trying to find out.

What participation involves

  • Time periods mentioned: 4 weeks
  • Procedures mentioned: Questionnaires

Only what the study's summary and detailed description on ClinicalTrials.gov say. Time periods may describe the whole study or a part of it — ask the study team what applies to you.

Show the study's own words
  • "Does a self-managed speech protocol lead to increased social participation, as measured by the Communicative Participation Item Bank and the Communicative Effectiveness Index questionnaires?"
  • "Engage in speech treatment sessions at home using their phone and computer four days a week for four weeks."
  • "In the first assessment session participants will be asked to complete voice recordings and three questionnaires."
  • "Participants will complete the same speech tasks and questionnaires in the rest of the assessment sessions."
  • "Participants will be instructed to complete 1-hour of speech exercises 4 days a week for 4 weeks."
Compensation
Not stated
  • Study-related exams and procedures are typically provided at no cost. This is how many trials work in general — confirm the details for this study with the study team.
  • Participants are monitored closely by the research team throughout the study.
  • Some participants may receive access to an investigational treatment, which is still being studied.
  • Your participation helps researchers learn whether this approach could help future patients.

About this study

The goal of this clinical trial is to learn whether noise-augmented feedback using automatic speech recognition improves intelligibility and social participation in individuals with Parkinson's disease. The main questions the investigators will address are: Does noise-augmented feedback lead to increased intelligibility, as measured by transcription accuracy scores? Does a self-managed speech protocol lead to increased social participation, as measured by the Communicative Participation Item Bank and the Communicative Effectiveness Index questionnaires? Participants will: Receive 2-4 initial speech assessments in-person in our lab. Engage in speech treatment sessions at home using their phone and computer four days a week for four weeks. Four of those sessions will be directly monitored online by a speech-language pathologist. The rest of the sessions are completed by the participant. Come to the lab for two post-treatment assessments following completion of treatment. Come to the lab six months after treatment completion for an additional assessment.

Compensation is read from the study's own description and may be missing — always confirm with the study team.

Eligibility

Official eligibility criteria

Inclusion Criteria: * Participants will qualify for the study if: * They are 50-80 years old, * They have a medical diagnosis of PD, * They are within stages I-IV of Hoehn \& Yahr Scale, * Their antiparkinsonian medication schedule is stable, * They present with mild to moderate dysarthria, * They score ≥ 25 in the MMSE, * They score ≤ 24 in the BDI-III. Exclusion Criteria: * Participants will be excluded from the study if they: * Present with atypical parkinsonism at the time of screening (or other neurological condition), * Underwent neurosurgery treatment (DBS), * Received intensive voice-focused treatment less than three months prior to their involvement in the current study, * Present with any speech or voice pathology that is unrelated to PD.

Study sites (1)

NY